Target intelligence / Profile preview

Calcium Channel Protein Alpha 1 Subunit (CaV Alpha 1 Subunit)

Target
CaV Alpha 1 Subunit
Molecular classification
Ion channel, Voltage-gated ion channel, Calcium channel, Transmembrane protein
01

Overview

The calcium channel protein alpha 1 subunit is the principal pore-forming component of voltage-gated calcium channels (VGCCs), responsible for the selective influx of Ca2+ ions into cells upon membrane depolarization. This process is critical for numerous physiological functions, including muscle contraction, neurotransmitter release, gene expression, and cardiac action potentials. There are ten known genes encoding alpha 1 subunits in humans, grouped into L-type, P/Q-type, N-type, R-type, and T-type channels, each with distinct tissue distribution and function. It determines most biophysical properties of VGCCs including ion selectivity, gating kinetics, voltage sensitivity, and pharmacological profile. Accessory subunits modulate trafficking and gating. Alpha 1 subunits are targeted by clinically important drugs for cardiovascular and neurological disorders. Mutations in specific genes are linked to various diseases.

Other names
Voltage-gated calcium channel alpha 1 subunitVGCC alpha 1 subunitCACNA1 subunitsCaV1.x, CaV2.x, CaV3.x channels
02

Mechanism of action

Selective influx of Ca2+ ions into cells upon membrane depolarization; modulation of channel activity by drugs and toxins.

03

Biological functions

Calcium ion transmembrane transportRegulation of membrane potentialMuscle contractionNeurotransmitter releaseGene expressionCardiac action potential regulationCell signaling
04

Disease associations

Cardiovascular diseaseNeurological disordersEpilepsyPainFamilial hemiplegic migraineTimothy syndromeCerebellar ataxiaAutism spectrum disorderArrhythmia
05

Safety considerations

Cardiovascular side effects (e.g., hypotension, bradycardia)Neurological side effects (e.g., dizziness, headache)Drug interactionsPotential for abuse/dependence (e.g., gabapentinoids)
06

Interacting drugs

Dihydropyridines (e.g., Nifedipine, Amlodipine)

5 more in the full profile.

Beyond the preview

Go deeper on Calcium Channel Protein Alpha 1 Subunit (CaV Alpha 1 Subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium Channel Protein Alpha 1 Subunit (CaV Alpha 1 Subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call